HLA-C and neoplasm: Interestingly, in a recent mouse model of vaccination against breast cancer, authors showed that the addition of YAC-1 (a NK target cell devoid of MHC) in a vaccine composed of irradiated tumor cells boosted the expansion of tumor-specific cytotoxic T lymphocytes, eventually resulting in enhanced survival of mice upon challenge with a lethal dose of tumor cells.